P5C inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axis
Lei Chang(University of California San Diego), Yutao Yan(First Affiliated Hospital of Jiangxi Medical College), Shan Jiang(Hubei University of Medicine), Guohao Li(Central Hospital of Wuhan), Yonglian Guo(Aerospace Center Hospital), Zhiguo Luo(Hubei University of Medicine), Hanrui Song(Hubei University of Medicine), Le Zhou(Yangzhou University), Jin Yang(Hubei University of Medicine), Kavita Shah(Purdue University West Lafayette), Leyuan Deng(Hubei University of Medicine), Jie Li(Union Hospital)
Cited by 0
Related Papers
Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates
|Proceedings of the National Academy of Sciences|1997|418
Unnatural Ligands for Engineered Proteins: New Tools for Chemical Genetics
|Annual Review of Biophysics and Biomolecular Structure|2000|157
Generation of Monospecific Nanomolar Tyrosine Kinase Inhibitors via a Chemical Genetic Approach
|Journal of the American Chemical Society|1999|155
A Chemical Genetic Screen for Direct v-Src Substrates Reveals Ordered Assembly of a Retrograde Signaling Pathway
|Chemistry & Biology|2002|148